Trials / Completed
CompletedNCT00932477
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The safety and tolerability of two new artificial tears will be compared to a currently-available artificial tear in subjects with dry eye. Each subject will receive all three products in a randomly assigned order. The subject will use one product at a time for a duration of one week before switching to the next assigned product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formulation 1: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear | 1 to 2 drops into each eye three times per day |
| DRUG | Formulation 2: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear | 1 to 2 drops into each eye three times per day |
| DRUG | Glycerin and Polysorbate 80 based artificial tear | 1 to 2 drops into each eye three times per day |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2009-07-03
- Last updated
- 2015-08-26
- Results posted
- 2011-12-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00932477. Inclusion in this directory is not an endorsement.